CD8A and neoplasm: Results showed that the number of CD8+ tumor-infiltrating lymphocytes in the two monotherapy groups were higher than that in the control group, the combination therapy group exhibit highest CD8+ T cell infiltrating when compared with two monotherapy groups (Fig. 2c).